Provided by Tiger Fintech (Singapore) Pte. Ltd.

ARCELLX, INC.

58.25
-1.2500-2.10%
Post-market: 58.250.00000.00%18:13 EDT
Volume:750.83K
Turnover:43.71M
Market Cap:3.21B
PE:-19.43
High:59.93
Open:59.77
Low:57.24
Close:59.50
Loading ...

Arcellx Inc (ACLX) Receives a Buy from Scotiabank

TIPRANKS
·
09 Dec 2024

Analysts Are Bullish on Top Healthcare Stocks: Merus (MRUS), Arcellx Inc (ACLX)

TIPRANKS
·
09 Dec 2024

Arcellx Shares up 6.5% Premarket on Positive Mid-Stage Trial Data for Blood Cancer Cell Therapy

THOMSON REUTERS
·
09 Dec 2024

BUZZ-Arcellx climbs on positive trial data for blood cancer cell therapy

Reuters
·
09 Dec 2024

Arcellx Price Target Maintained With a $105.00/Share by Needham

Dow Jones
·
09 Dec 2024

Arcellx Says Trial of Multiple Myeloma Drug Candidate Achieves 97% Overall Response Rate

MT Newswires Live
·
09 Dec 2024

BRIEF-Arcellx Says Three Deaths Due To Treatment-Emergent Adverse Events In Anito-Cel Study

Reuters
·
09 Dec 2024

Arcellx Announces New Positive Data for Its Immagine-1 Study in Patients With Relapsed or Refractory Multiple Myeloma to Be Presented During an Oral Presentation at the 66TH Ash Annual Meeting and Exposition

THOMSON REUTERS
·
09 Dec 2024

Arcellx Inc - Three Deaths Due to Treatment-Emergent Adverse Events in Anito-Cel Study

THOMSON REUTERS
·
09 Dec 2024

Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients With Relapsed or Refractory Multiple Myeloma to be Presented During an Oral Presentation at the 66th ASH Annual Meeting and Exposition

Business Wire
·
09 Dec 2024

Arcellx Inc : Barclays Raises Target Price to $115 From $73

THOMSON REUTERS
·
02 Dec 2024

Arcellx price target raised to $115 from $73 at Barclays

TIPRANKS
·
01 Dec 2024

Scotiabank Sticks to Its Buy Rating for Arcellx Inc (ACLX)

TIPRANKS
·
18 Nov 2024